Clinical trial
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders
NCT07771517 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 14, 2027
- Completion date
- May 20, 2029
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
major depressive disorder (mdd)